We are thrilled to announce the recipients of the 2024 PRiME Fellowship – Round 2! These outstanding fellows are leading the way for the next generation of scientific innovators, pushing the boundaries of interdisciplinary research in precision medicine.
In collaboration with the Ontario Institute for Cancer Research (OICR) and Women’s College Hospital (WCH), these fellowships support exceptional trainees who are breaking new ground in molecular biology, genomics, computational biology, and bioengineering—paving the way for advancements in drug discovery, diagnostics, and disease biology.
“Congratulations to the PRiME Fellows and their teams! This cohort exemplifies the power of collaboration between the University of Toronto’s world-class research community and leading institutions like WCH and OICR,” said Professor Molly Shoichet, Scientific Director of PRiME. “Their innovative work is a critical step forward in precision medicine, integrating diverse expertise across biologics, omics, and disease biology to address pressing health challenges. We are deeply grateful for their dedication and contributions.”
Introducing the 2024 PRiME Fellowship Awardees:
Emily Majaesic
PhD Candidate
Project Title:
Towards the development of nanopore-based protein sequencing
Co-Supervisors:
Prof. Walid Houry, University of Toronto
Dr. Jared Simpson, Ontario Institute for Cancer Research
Liting Wang
Postdoctoral Fellow
Project Title:
Brain-penetrating drug combination nanoparticles target integrins and CD44-mediated pathways to enhance chemotherapy of glioblastoma
Co-Supervisors:
Prof. Shirley X.Y. Wu, University of Toronto
Dr. Ahmed Aman, Ontario Institute for Cancer Research
Dr. Laurie Ailles, Princess Margaret Cancer Centre, UHN
Abdullah Bin Shams
PhD Candidate
Project Title:
Highly sensitive novel early cancer detection platform based on metasurfaces
Co-Supervisors:
Prof. J. Stewart Aitchison, University of Toronto
Dr. Mohammad R. Akbari, Women’s College Hospital
“Congratulations to the winners! The PRiME community provides exceptional opportunities for both Principal Investigators and Fellows,” said Akshita Vincent, Director, Strategy & Partnerships, PRiME. “Through collaborative research, specialized workshops, industry events, and our Annual Symposium, we cultivate a vibrant environment that drives breakthrough discoveries and advances the field of precision medicine.”
Congratulations to the PRiME Fellows!